Piramal Healthcare is a leading pharmaceutical, supplying pharmaceutical product and across all international markets. The site at Morpeth is approved by all the major regulatory bodies including MHRA and FDA and offers the capability to manufacture Phase I - III clinical trials materials, clinical trials packaging and distribution through to commercial volumes of API and solid dosage drug products, either as bulk or in end user packaging. We are dedicated to offering a full service across the whole product lifecycle and from the API to final drug product; all from a single location.
9 Apr 2021
Piramal Pharma Agrees to Acquire Hemmo Pharmaceuticals
CDMO Piramal Pharma Solutions (PPS), based in Mumbai, India, agreed to acquire a 100% stake in Hemmo Pharmaceuticals in a deal that will add peptide API development and manufacturing capabilities to PPS’ operations. Hemmo, which is one of the few…